NCT06681220 2026-03-11
Relapsed SCLC
VA Office of Research and Development
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05467748 2026-01-27
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
VA Office of Research and Development
Phase 1/2 Recruiting
NCT05842174 2026-01-22
TAQE
VA Office of Research and Development
Phase 1/2 Not yet recruiting
NCT05687721 2025-06-15
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
VA Office of Research and Development
Phase 1/2 Withdrawn